The case for early use of glucagon-like peptide-1 receptor agonists in obstructive sleep apnea patients with comorbid diabetes and metabolic syndrome
Nicole Fallert: I think because we're seeing people who are using the brand name close gaps and balance with the gray, if I'm going to be pessimistic, I would say they are a more permanent part
When compared to controls, the two drugs efficiently reduced glycemia and weight in T2D, obesity, or both
Eric Topol (08:27): Well, inspired a whole industry is an understatement
Exploring the Link Between GLP-1 Medications and Eye Health GLP-1 medications including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have revolutionized treatment for obesity and type 2 diabetes
El primer GLP-1, la exenatida (Byetta), fue aprobado por primera vez por la Administracin de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en ingls) en 2009 como un inyectable dos veces al da, que debe administrarse dentro de una hora de las comidas de la maana y la noche
